CCDC 164448: Experimental Crystal Structure Determination
J.E. Baldwin, A. Mayweg(Roche (Switzerland)), Paul G. Bulger(MACOM (United States)), Rafael Márquez, Fanny Roussi(University of Oxford), Robert M. Adlington(Loughborough University)
Cited by 0
Related Papers
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
|ACS Medicinal Chemistry Letters|2014|174
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
|Circulation|2023|141
β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
|Journal of Medicinal Chemistry|2013|138
Late-Stage Intermolecular CH Activation for Lead Diversification: A Highly Chemoselective Oxyfunctionalization of the C-9 Position of Potent Bryostatin Analogues
|Organic Letters|2004|97
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors
|Journal of Medicinal Chemistry|2016|75